Sam just said that if someone comes up with a fundamentally superior (more compute efficient) approach for scaling powerful AI models, OpenAI will be in a “not great” place.
This should be our primary focus for AI acceleration — not blindly worshiping the Transformer.
We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!
This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people.
Recruitment is not yet open for our clinical trial. We’ll announce more information on this soon!
They call him Big Moe. 🦈
Join the search for the world's largest hammerhead and watch Monster Under the Bridge right now on @discoveryplus. https://t.co/mNS9Krg0mV
#SharkWeek ✖️ #discoveryplus